<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-120843" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Primary Lung Tuberculosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alzayer</surname>
            <given-names>Zainab</given-names>
          </name>
          <aff>University of Dammam</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Nasser</surname>
            <given-names>Yasser</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zainab Alzayer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasser Al Nasser declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-120843.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tuberculosis is the leading cause of death from an infectious agent worldwide, causing even more deaths in patients with HIV/AIDS. A third of the world's population is said to have contracted the bacteria responsible for tuberculosis, Mycobacterium tuberculosis, with estimates of ten million new infections globally each year. This activity reviews the evaluation and management of primary pulmonary tuberculosis.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the etiology of primary pulmonary tuberculosis.</p></list-item><list-item><p>Outline the evaluation of patients presenting with primary pulmonary tuberculosis.</p></list-item><list-item><p>Review the management options available for primary pulmonary tuberculosis.</p></list-item><list-item><p>Describe some interprofessional team strategies that can result in better care coordination for patients presenting with primary pulmonary tuberculosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=120843&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=120843">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-120843.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Discovered in 1882 by Robert Koch, tuberculosis (TB), one of the oldest known infections, is a major global health problem and&#x000a0;one of the top ten causes of death worldwide. It is a disease of humans, as it does not affect animals naturally.<xref ref-type="bibr" rid="article-120843.r1">[1]</xref><xref ref-type="bibr" rid="article-120843.r2">[2]</xref></p>
        <p>Tuberculosis is the leading cause of death from an infectious agent worldwide, causing even more deaths in HIV/AIDS patients. A third of the world's population is said to&#x000a0;have contracted the bacteria responsible for tuberculosis,&#x000a0;<italic toggle="yes">Mycobacterium tuberculosis, </italic>with estimates of ten million new infections globally each year.<xref ref-type="bibr" rid="article-120843.r3">[3]</xref><xref ref-type="bibr" rid="article-120843.r4">[4]</xref>&#x000a0;The global disease burden of tuberculosis is estimated to be around 24%, with remarkable socioeconomic implications.<xref ref-type="bibr" rid="article-120843.r5">[5]</xref>&#x000a0;</p>
        <p>The major pathology in tuberculosis is&#x000a0;necrotizing granulomatous inflammation, with&#x000a0;the lungs being the primary organs&#x000a0;of involvement of the disease in up to 87% of the cases. Having that said, almost any bodily organ could be a site&#x000a0;for the disease.<xref ref-type="bibr" rid="article-120843.r6">[6]</xref><xref ref-type="bibr" rid="article-120843.r7">[7]</xref>&#x000a0;It commonly affects people living in crowded conditions such as institutionalized patients, immigrants from countries with a high prevalence of tuberculosis, immunocompromised such as patients with HIV, and health care workers.<xref ref-type="bibr" rid="article-120843.r8">[8]</xref><xref ref-type="bibr" rid="article-120843.r9">[9]</xref>&#x000a0;</p>
        <p>The worldwide incidence has been steadily decreasing, but it is still a common problem in regions such as&#x000a0;Sub-Saharan Africa. It is still a major medical cause of mortality as the global death toll reaches up to 1.5 million deaths a year.<xref ref-type="bibr" rid="article-120843.r10">[10]</xref>&#x000a0;Lung function impairment is the major sequel of pulmonary tuberculosis.<xref ref-type="bibr" rid="article-120843.r11">[11]</xref> In this topic, we will review pulmonary tuberculosis covering the main aspects of the disease.</p>
      </sec>
      <sec id="article-120843.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Mycobacterium</italic>&#x000a0;species include a variety of organisms with different genomic structures, morphology, and tropism.<xref ref-type="bibr" rid="article-120843.r12">[12]</xref>&#x000a0;The genus itself includes more than 170 species.<xref ref-type="bibr" rid="article-120843.r13">[13]</xref>&#x000a0;<italic toggle="yes">M. tuberculosis</italic> is a gram-negative bacteria. It is a small, aerobic, and nonmotile bacillus.&#x000a0;It is characterized by a complex wall structure that is rich in long-chain fatty acids. The genus is divided into two groups: fast-growing and slow-growing organisms. <italic toggle="yes">M. tuberculosis</italic> belongs to the slow-growing group.<xref ref-type="bibr" rid="article-120843.r14">[14]</xref>&#x000a0;<italic toggle="yes">M.&#x000a0;tuberculosis</italic> cell wall is rich in peptidoglycan&#x000a0;and complex lipids. These structures are major factors for pathogenesis.<xref ref-type="bibr" rid="article-120843.r15">[15]</xref>&#x000a0;The capsule (the outer layer) surrounds the cell wall. It is a main contributor to the bacterium's virulence and survival.</p>
        <p><italic toggle="yes">M. tuberculosis</italic> is a&#x000a0;facultative intracellular bacterium. It acts as an inhibitor of macrophages, proliferates within the macrophages, causing the eventual death of invaded macrophages and the release of the bacillus to the alveolar space.<xref ref-type="bibr" rid="article-120843.r16">[16]</xref>&#x000a0;Staining with stains such as Ziehl-Neelsen aid in detecting the acid-fast bacilli using microscopy. <italic toggle="yes">Mycobacterium tuberculosis</italic> is a very slow-growing organism, taking up to 24 hours to grow.<xref ref-type="bibr" rid="article-120843.r17">[17]</xref></p>
      </sec>
      <sec id="article-120843.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Tuberculosis is a reportable disease in almost all world countries. This facilitates more accurate disease tracking and epidemiological studies. The incidence of&#x000a0;tuberculosis was slowly decreasing until the surge of HIV infection, which led to this trend reversal.<xref ref-type="bibr" rid="article-120843.r18">[18]</xref><xref ref-type="bibr" rid="article-120843.r19">[19]</xref> Among medical conditions, tuberculosis is now a leading cause of mortality and morbidity across the globe.&#x000a0;Different studies estimate that around 1.7 billion individuals have been infected with tuberculosis.<xref ref-type="bibr" rid="article-120843.r5">[5]</xref>&#x000a0;TB caused around 2.5% of the world's deaths in 2004.<xref ref-type="bibr" rid="article-120843.r20">[20]</xref></p>
        <p>The WHO estimated that it infected 10 million individuals in the year 2017. Among world countries, India and China are leading in TB deaths.<xref ref-type="bibr" rid="article-120843.r20">[20]</xref>&#x000a0;Countries with a high poverty rate are primarily affected, with an estimated incidence of 183 cases per 100,000, compared to less than ten per 100,000 in developed countries.<xref ref-type="bibr" rid="article-120843.r21">[21]</xref>&#x000a0;However, the universal incidence is slowly decreasing by 1.6% per year.<xref ref-type="bibr" rid="article-120843.r22">[22]</xref>&#x000a0;Among HIV patients, TB is the main culprit for mortality.&#x000a0;CD4 cells have a major role in combating HIV infection. Hence advanced HIV disease is typically associated with disseminated disease.<xref ref-type="bibr" rid="article-120843.r23">[23]</xref><xref ref-type="bibr" rid="article-120843.r24">[24]</xref>&#x000a0;</p>
        <p>Several other medical conditions and certain medications also increase the risk of developing TB infection. This includes diabetes, chronic corticosteroid use, and the use of anti-TNF biologics. A unique group at risk are patients who underwent gastrectomy, which appears to be due to certain nutritional deficiencies.<xref ref-type="bibr" rid="article-120843.r25">[25]</xref>&#x000a0;Some rare genetic defects affecting gamma interferon, IL-12, and IL-23 signaling pathways put patients at increased risk for more severe disease.<xref ref-type="bibr" rid="article-120843.r26">[26]</xref></p>
        <p>Tuberculosis transmits via&#x000a0;aerosolized microdroplets.&#x000a0;This is classically generated from a coughing patient with active tuberculosis. Other means of generating aerosolized droplets include singing, shouting, and sneezing.<xref ref-type="bibr" rid="article-120843.r27">[27]</xref> Prolonged exposure is the main factor in increasing the risk of transmission. Thus it is a common occurrence among household members and coworkers.<xref ref-type="bibr" rid="article-120843.r28">[28]</xref>&#x000a0;Other common places for tuberculosis transmission include prisons, mines, and public transport settings.<xref ref-type="bibr" rid="article-120843.r29">[29]</xref><xref ref-type="bibr" rid="article-120843.r30">[30]</xref>&#x000a0;Smear-positive patients are considered highly infectious.<xref ref-type="bibr" rid="article-120843.r31">[31]</xref>&#x000a0;The cavitary disease also seems to increase transmission as cavitation erodes the airways the technically facilitates bacterium movement.<xref ref-type="bibr" rid="article-120843.r32">[32]</xref>&#x000a0;Children below 5 years and HIV-positive patients&#x000a0;are at a higher risk of contracting the disease.<xref ref-type="bibr" rid="article-120843.r33">[33]</xref></p>
      </sec>
      <sec id="article-120843.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Tuberculosis pulmonary inflammation is characterized by lung tissue destruction and necrosis, unlike other lung infections that affect mainly the airways.<xref ref-type="bibr" rid="article-120843.r34">[34]</xref> The main virulence factors that play roles in&#x000a0;the pathogenesis of <italic toggle="yes">M. tuberculosis</italic> include cell wall mycolic acid glycolipids, lipoarabinomannan (LAM), sulfatides, and trehalose dimycolate.<xref ref-type="bibr" rid="article-120843.r35">[35]</xref>&#x000a0;The exact role each factor plays is not very understood. The virulence effect varies as there are factors that help evade local immune cells, induce cytokines, and another affecting cellular metabolism.<xref ref-type="bibr" rid="article-120843.r36">[36]</xref>&#x000a0;Mce1A protein, although still not clear how plays an important role in tuberculosis cellular transport.<xref ref-type="bibr" rid="article-120843.r37">[37]</xref>&#x000a0;</p>
        <p><italic toggle="yes">M. tuberculosis</italic> cell wall also contains different kinds of mycolic acids that are integral to the organism growth inside macrophages.<xref ref-type="bibr" rid="article-120843.r38">[38]</xref>&#x000a0;Other virulence secretion systems have also been described. Examples are ESX-1, sec, and TAT systems. These systems facilitate the mycobacterium translocation.<xref ref-type="bibr" rid="article-120843.r39">[39]</xref>&#x000a0;</p>
        <p>Unlike most gram-negative bacteria, the main virulence factor of&#x000a0;tuberculosis evolves around "survival" within its human host, rather than actively attacking the host or evading its defenses. The main example is when it develops cholesterol uptake mechanisms from the host to enhance its survival.<xref ref-type="bibr" rid="article-120843.r40">[40]</xref></p>
      </sec>
      <sec id="article-120843.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The main pathological feature of tuberculosis is "granuloma formation," a rounded collection of macrophages surrounded by lymphocytes. The unique feature differentiating tuberculous granulomas from other infectious granulomatous conditions (such as Histoplasma and Leishmania) is "caseation" or central necrosis.<xref ref-type="bibr" rid="article-120843.r34">[34]</xref></p>
      </sec>
      <sec id="article-120843.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>After primary infection, the majority of patients remain asymptomatic. Most of these asymptomatic individuals clear the infection. However, a portion enters a "latent" phase with the potential "reactivation" in the future.<xref ref-type="bibr" rid="article-120843.r41">[41]</xref>&#x000a0;Symptomatic individuals (around 10 percent) develop primary lung infection with some suffering spread to distant organs, particularly immune-compromised patients (e.g., HIV patients).<xref ref-type="bibr" rid="article-120843.r42">[42]</xref>&#x000a0;Prolonged fever is the most commonly reported symptom as only one-third of patients with pulmonary involvement develop respiratory symptoms. This fever usually follows a diurnal pattern. It increased as the day goes and subsides at night, although sometimes it is associated with night sweat.<xref ref-type="bibr" rid="article-120843.r43">[43]</xref>&#x000a0;Pulmonary symptoms include chest pain, shortness of breath, and cough. Cough is often mild and non-productive. However, in disease progression, it might produce green or blood-tinged sputum. Other nonpulmonary symptoms may occur, such as lymphadenopathy, fatigue, and pharyngitis.<xref ref-type="bibr" rid="article-120843.r44">[44]</xref>&#x000a0;Anorexia, weight loss, and loss of muscle mass could happen in advanced cases.<xref ref-type="bibr" rid="article-120843.r45">[45]</xref>&#x000a0;</p>
        <p>Latency is a unique aspect of tuberculosis infection. The majority of infected individuals who get infected do not actually develop symptoms until months to years after their initial exposure. This is known as latent tuberculosis.<xref ref-type="bibr" rid="article-120843.r46">[46]</xref>&#x000a0;Research is inconclusive about this stage, but most point towards the bacterium entering a static no-growth state.<xref ref-type="bibr" rid="article-120843.r47">[47]</xref>&#x000a0;Reactivation of tuberculosis is a prolonged process that could sometimes take years to progress.<xref ref-type="bibr" rid="article-120843.r48">[48]</xref>&#x000a0;Symptoms are not very different from primary disease and classically include fever, cough, shortness of breath, and weight loss.<xref ref-type="bibr" rid="article-120843.r49">[49]</xref></p>
        <p>The physical exam is usually normal in mild disease or shows nonspecific lung findings such as crackles or tubular breath sounds. Absent breath sounds are noted over consolidation areas. Extrapulmonary findings include clubbing and other signs of distant organ involvement.<xref ref-type="bibr" rid="article-120843.r50">[50]</xref></p>
      </sec>
      <sec id="article-120843.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The workup of suspected TB cases begins with a chest radiograph. The workup should be initiated in any patients with more than&#x000a0;three weeks of cough and additional symptoms such as fever, night sweats, hemoptysis, or weight loss. The workup should also be initiated in at-risk groups with prolonged unexplained illnesses.&#x000a0;These at-risk groups&#x000a0;include the following: HIV-positive patients, individuals with known recent exposure to a case of active tuberculosis, low socioeconomic status, chronic illnesses (such as diabetes, chronic kidney disease, malignancy, or patient on immune suppressive), and IV drug users.<xref ref-type="bibr" rid="article-120843.r51">[51]</xref></p>
        <p>If imaging is suggestive of infection three sputum samples should be collected and sent for acid-fast bacilli (AFB) staining with one sample tested with nucleic acid amplification (NAAT). If both AFB culture and NAAT are positive, TB is likely and treatment should be initiated. Tuberculin skin test (TST) and interferon-gamma release assay (IGRA) should be added to the workup as they support the diagnosis, however, negative results don't exclude the infection.<xref ref-type="bibr" rid="article-120843.r51">[51]</xref>&#x000a0;In the case of non-definitive results, a bronchoscopy sample to lung biopsy could be considered.<xref ref-type="bibr" rid="article-120843.r52">[52]</xref></p>
        <p>
<bold>Radiological Findings</bold>
</p>
        <p>Early in the disease, chest radiographs are usually normal. Hilar lymphadenopathy is a hallmark of radiological findings in tuberculosis. Other common findings include perihilar and right-sided infiltration and pleural effusion.</p>
      </sec>
      <sec id="article-120843.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In 2016, international guidelines were developed to treat drug-susceptible tuberculosis, led by the Americal Thoracic Society and Center for Disease Control and Prevention (CDC) with the participation of various US and international organizations.<xref ref-type="bibr" rid="article-120843.r53">[53]</xref>&#x000a0;The main goals of treatment are decreasing the burden of growing bacilli, preventing relapse, and decreasing drug resistance.&#x000a0;<xref ref-type="bibr" rid="article-120843.r53">[53]</xref>&#x000a0;The drug therapy of active tuberculosis is divided into two main phases: the intensive phase (lasting for two months) and followed by the continuation phase (lasting at least four months). The standard drug choice for the intensive phase is isoniazid (INH), ethambutol (EMB), rifampin (RIF), and pyrazinamide (PZA). The continuation phase drugs are usually isoniazid and rifampin.<xref ref-type="bibr" rid="article-120843.r54">[54]</xref><xref ref-type="bibr" rid="article-120843.r55">[55]</xref> Medications should be administered through what is known as directly observed therapy (DOT), which is observing the patient directly ingesting the medicine to enhance patient compliance and therapy adherence.<xref ref-type="bibr" rid="article-120843.r56">[56]</xref> AFB culture should be done monthly during treatment until at least two consecutive negative samples.<xref ref-type="bibr" rid="article-120843.r53">[53]</xref></p>
        <p>The preferred regimen is the combination of&#x000a0;INH, RIF, PZA, and EMB for the intensive phase for 8 weeks (56 doses) and INH and RIF for the continuation phase for 18 weeks (126 doses). The medications are given daily, 7 days a week. If there is a concern about compliance or difficulty achieving DOT, the dosing for the continuous phase could be modified to 3 times weekly. When drug sensitivity is available, and the bacterium is susceptible to both INH and RIF, EMB could be stopped.<xref ref-type="bibr" rid="article-120843.r57">[57]</xref>&#x000a0;Patients at risk of neuropathy, such as pregnant/lactating mothers, breastfed infants, diabetics, chronic kidney disease, alcoholic, older age, and HIV positive patients, should receive&#x000a0;pyridoxine (vitamin B6) supplementation.<xref ref-type="bibr" rid="article-120843.r58">[58]</xref></p>
        <p>Treatment of tuberculosis in HIV-positive patients constitutes a unique challenge due to potential drug interaction with antiretroviral therapy. In general, it is still recommended to use the same duration of treatment for both intensive and continuation phases (two and four months) in HIV-positive patients who are infected with drug-susceptible tuberculosis. The exception is an unusual situation when the patient is not receiving antiretroviral therapy. In this situation, it is suggested that the continuation phase is continued for 3 additional months.<xref ref-type="bibr" rid="article-120843.r59">[59]</xref>&#x000a0;The concomitant use of&#x000a0;trimoxazole and anti-tuberculous drugs has been shown to improve outcomes in HIV patients with active tuberculosis, particularly those with a CD4 count below 200&#x000a0;cells/&#x000b5;L.<xref ref-type="bibr" rid="article-120843.r60">[60]</xref></p>
        <p>Latent tuberculosis infection (LTBI) is treated with fewer medications for a shorter period of time.&#x000a0;2020 LTBI treatment guidelines include the NTCA- and CDC-recommended treatment regimens that comprise three preferred rifamycin-based regimens and two alternative monotherapy regimens with daily isoniazid. These are only recommended for persons infected with&#x000a0;<italic toggle="yes">Mycobacterium tuberculosis</italic>&#x000a0;that is presumed to be susceptible to isoniazid or rifampin.&#x000a0;A regimen of 3 months of once-weekly isoniazid plus rifapentine is a preferred regimen that is strongly recommended for children aged more than 2 years and adults. Another option is&#x000a0;4 months of daily rifampin for HIV-negative adults and children of all ages. Three&#x000a0;months of daily isoniazid plus rifampin is a preferred treatment that is conditionally recommended for adults and children of all ages and for patients with HIV.&#x000a0;Regimens of 6 or 9 months of daily isoniazid are alternative recommended regimens.</p>
        <p>In general, severe treatment side effects that warrant cessation of medications occur in&#x000a0;4% to 9% of patients receiving conventional drug therapy.<xref ref-type="bibr" rid="article-120843.r61">[61]</xref>&#x000a0;Most commonly reported side effects include nausea, vomiting, and skin rashes.<xref ref-type="bibr" rid="article-120843.r62">[62]</xref>&#x000a0;Laboratory monitoring of liver toxicity should be initiated. Significant hepatotoxicity occurs in 2.4% of cases and mandates halting treatment temporarily. Elevated liver enzymes 3 to 5 times above normal limits and elevated serum bilirubin prompt holding therapy until they normalize. According to referenced guidelines, medications are then reintroduced one by one to identify the culprit and substitute it with another medication.<xref ref-type="bibr" rid="article-120843.r63">[63]</xref><xref ref-type="bibr" rid="article-120843.r61">[61]</xref>&#x000a0;An optic neuroma is a rare event that could occur with ethambutol. Patients on this medication should have an ophthalmologic exam 4-weeks into treatment.<xref ref-type="bibr" rid="article-120843.r64">[64]</xref>&#x000a0;Neuropathy could happen with INH use, and risk could be lowered by concomitant use of pyridoxine.<xref ref-type="bibr" rid="article-120843.r63">[63]</xref></p>
        <p>
<bold>Drug-resistant Tuberculosis</bold>
</p>
        <p>Drug resistance is a major problem in treating tuberculosis.&#x000a0;<xref ref-type="bibr" rid="article-120843.r65">[65]</xref>&#x000a0;Patients resistant to INH and RIF are said to have multidrug-resistant (MDR) TB. It is a major challenge that could arise during treatment. The chance of developing MDR TB is around&#x000a0;3.8% in developed countries. However, this number could be much higher in countries with a high TB burden, such as China and India, reaching up to 20%.<xref ref-type="bibr" rid="article-120843.r66">[66]</xref>&#x000a0;Drug-resistant TB is categorized into different types:</p>
        <p>Mono-resistant TB: Resistance to one of the drugs of standard first-line medications.</p>
        <p>Polydrug resistance: Resistance to more than one first-line medication (except the combination of INH and RIF).</p>
        <p>Multidrug resistance (MDR): Resistance to both INH and RIF</p>
        <p>Extensive drug resistance (XDR): MDR plus resistance to a fluoroquinolone and injectable second-line medications.<xref ref-type="bibr" rid="article-120843.r67">[67]</xref></p>
        <p>There are multiple settings where drug resistance could develop. Nonstandardized treatment protocols among countries or medication shortages in resource-limited countries lead to incomplete treatment.<xref ref-type="bibr" rid="article-120843.r67">[67]</xref>&#x000a0;Community and nosocomial transmission are also other major sources of MDR-TB spread.<xref ref-type="bibr" rid="article-120843.r68">[68]</xref>&#x000a0;Drug-susceptibility testing (DST) is required to diagnose MDR-TB. Currently, there are different commercially available molecular testing that identify genes conferring drug resistance.<xref ref-type="bibr" rid="article-120843.r69">[69]</xref>&#x000a0;</p>
        <p>There are multiple second-line drugs for MDR, but unfortunately, the cure rate is much lower than drug-susceptible tuberculosis. The global cure rate is variable between countries. Surveys reported cure rates between 20 to 48%.<xref ref-type="bibr" rid="article-120843.r67">[67]</xref>&#x000a0;As a rule, any medication that was used in first-line regimens should be excluded from second-line therapy. DST and history should guide second-line therapy. Classically the regimen consists of four drugs. The first step is to choose an injectable medication. Examples include kanamycin and capreomycin. Adding a&#x000a0;fluoroquinolone such as&#x000a0;moxifloxacin or levofloxacin is the next step. The third choice is one of these options: ethionamide, cycloserine, or para-aminosalicylic acid. The last step is to add either PZA or EMB to the regimen.<xref ref-type="bibr" rid="article-120843.r70">[70]</xref>&#x000a0;The duration of treatment of MDR-TB is a minimum of 20 months and for an additional 18 months after being culture negative.</p>
      </sec>
      <sec id="article-120843.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis can be broad, especially with respiratory involvement, but can include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sarcoidosis: Mainly differentiated from tuberculosis by the presence of non-caseating granuloma.</p>
          </list-item>
          <list-item>
            <p>Fungal infections: Such as&#x000a0; Histoplasmosis,&#x000a0;Aspergillosis,&#x000a0;Actinomycosis,&#x000a0;Blastomycosis, and&#x000a0;Nocardiosis. Epidemiological history aid in determining the risk of developing these infections.</p>
          </list-item>
          <list-item>
            <p>Nontuberculous mycobacterial infections (NTM): such as <italic toggle="yes">Mycobacterium kansasii</italic>.</p>
          </list-item>
          <list-item>
            <p>Lung malignancy and lymphoma: Tissue biopsy is needed to role out this diagnosis if suspected</p>
          </list-item>
          <list-item>
            <p>Lung abscess</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-120843.s11" sec-type="Treatment Planning ">
        <title>Treatment Planning </title>
        <p>Patients with active tuberculosis undergoing medical treatment should undergo organized monitoring and follow-up. Sputum sampling and culture with drug susceptibility testing should be done at the third and fourth months into treatment to verify negativity. A sample should also be obtained at the end of treatment. Chest X-rays or equivalent imaging should be obtained two months after treatment initiation and at the end of therapy. Vision assessment should be done monthly, starting the third month till the end of therapy. Screening for hepatitis B and C should be done at baseline for patients at risk (such as IV drug users). Monthly laboratory assessment should start after one month of therapy for blood cells (CBC), liver enzymes, and creatinine.&#x000a0;CD4 and RNA viral load should be assessed monthly for HIV-positive patients.<xref ref-type="bibr" rid="article-120843.r53">[53]</xref></p>
      </sec>
      <sec id="article-120843.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Tuberculosis prognosis is variable as it could be a multi-system disease and is affected&#x000a0;by many factors. Patient characteristics such as age, immune status, comorbidities, time of treatment initiation, and compliance have a significant impact on the outcome. In general, treatment is successful in about 85% of cases. The World Health Organization estimates the mortality rate to be at 15 percent.<xref ref-type="bibr" rid="article-120843.r9">[9]</xref></p>
      </sec>
      <sec id="article-120843.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Pulmonary tuberculosis has a variety of complications. Bleeding from bronchial, pulmonary, and intercostal arteries lead to hemoptysis. This bleeding is usually minimal and rarely leads to massive blood loss.<xref ref-type="bibr" rid="article-120843.r71">[71]</xref>&#x000a0;Rupture of a subpleural focus or a lung cavity could lead to spontaneous pneumothorax.<xref ref-type="bibr" rid="article-120843.r72">[72]</xref>&#x000a0;Lymph node inflammation may lead to compression on the bronchial tree and could cause bronchiectasis.<xref ref-type="bibr" rid="article-120843.r73">[73]</xref>&#x000a0;Severe untreated pulmonary tuberculosis may lead to extensive lung destruction, necrosis, and gangrene.<xref ref-type="bibr" rid="article-120843.r74">[74]</xref>&#x000a0;Tuberculosis has also been reported to increase the risk of lung malignancy.<xref ref-type="bibr" rid="article-120843.r75">[75]</xref>&#x000a0;Other less common complications include chronic pulmonary aspergillosis and septic shock.<xref ref-type="bibr" rid="article-120843.r76">[76]</xref><xref ref-type="bibr" rid="article-120843.r77">[77]</xref></p>
      </sec>
      <sec id="article-120843.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The most effective approach for tuberculosis disease prevention is identifying cases and effective treatment. Medical therapy considerably decreases bacterial load transmission within communities.<xref ref-type="bibr" rid="article-120843.r78">[78]</xref>&#x000a0;A vaccine does exist for tuberculosis, known as the BCG vaccine. This is an old vaccine with worldwide use, particularly in developing countries, usually given at birth or in infancy. The vaccine seems to decrease the incidence of tuberculosis in childhood but unfortunately does not affect the incidence of adulthood disease.<xref ref-type="bibr" rid="article-120843.r78">[78]</xref></p>
        <p>Using the <italic toggle="yes">FAST</italic> approach seems to effectively reduce the burden of nosocomial transmission in a hospital setting. This consists of <italic toggle="yes">Finding</italic> undiagnosed tuberculosis infections <italic toggle="yes">Actively</italic> through rapid molecular testing, <italic toggle="yes">Separating</italic> them safely, and initiating appropriate <italic toggle="yes">treatment</italic>.<xref ref-type="bibr" rid="article-120843.r79">[79]</xref></p>
        <p>Identifying and mapping "hot sport" within a geographical area and providing preventative INH therapy seems to decrease disease burden within communities.<xref ref-type="bibr" rid="article-120843.r80">[80]</xref></p>
        <p>Socioeconomic development (such as improving public transport settings) and improving nutritional health within communities reduce crowdedness and minimize close contact or prolonged exposure. This reduces the risk of community transmission and decreases the disease burden.<xref ref-type="bibr" rid="article-120843.r81">[81]</xref></p>
        <p>Several vaccine candidates have shown efficacy in animal models compared to the old BCG vaccine. However, none so far have shown efficacy in humans. One trial examined a vaccinia virus-produced <italic toggle="yes">M. tuberculosis</italic> vaccine has failed to elicit an adequate immune response in human hosts.<xref ref-type="bibr" rid="article-120843.r82">[82]</xref></p>
      </sec>
      <sec id="article-120843.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A national detection program should be implemented to help curb the disease burden in communities. These programs are responsible for sample processing and result feedback to treating healthcare professionals. Infection control is another integral part of improving the disease outcome. It requires coordination between public health, treating facilities, and the local community. Drug administration under directly observed therapy (DOT) requires feedback pathways between patients, observers, and treating healthcare professionals.&#x000a0;In most countries, the patients are assigned a "Case Manager" usually by public health. Communication between the patient and treating professional helps the case manager solve treatment problems and help achieve treatment goals.<xref ref-type="bibr" rid="article-120843.r83">[83]</xref></p>
        <p>Effective patient education about tuberculosis infection, treatment objectives, medications, and their side effects, appropriate infection-control measures vastly improve chances of treatment success and prognosis. Healthy educators and pharmacists play crucial roles here and must be utilized where available.<xref ref-type="bibr" rid="article-120843.r84">[84]</xref></p>
        <p>All these different medical disciplines need to function as a cohesive, collaborative interprofessional healthcare team to improve patient outcomes.</p>
        <p>Drug-resistant TB is a major problem now. Communication between clinical pharmacists and treating health professional help in selecting appropriate therapy and minimizes unnecessary drug exposure.</p>
      </sec>
      <sec id="article-120843.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=120843&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=120843">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/primary-lung-tuberculosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=120843">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/120843/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=120843">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-120843.s17">
        <title>References</title>
        <ref id="article-120843.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Churchyard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Rustomjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gandhi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mathema</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dowdy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kasmar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cardenas</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>What We Know About Tuberculosis Transmission: An Overview.</article-title>
            <source>J Infect Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <day>03</day>
            <volume>216</volume>
            <issue>suppl_6</issue>
            <fpage>S629</fpage>
            <page-range>S629-S635</page-range>
            <pub-id pub-id-type="pmid">29112747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wirth</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The Evolutionary History, Demography, and Spread of the Mycobacterium tuberculosis Complex.</article-title>
            <source>Microbiol Spectr</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">27726798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis.</article-title>
            <source>Lancet</source>
            <year>2019</year>
            <month>Apr</month>
            <day>20</day>
            <volume>393</volume>
            <issue>10181</issue>
            <fpage>1642</fpage>
            <page-range>1642-1656</page-range>
            <pub-id pub-id-type="pmid">30904262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sudarsan</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Samprathi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chacko</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mathuram</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Karthik</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rajan</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>RAB</given-names>
              </name>
              <name>
                <surname>Mahasampath</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous ARDS is associated with worse outcome when compared with non-tuberculous infectious ARDS.</article-title>
            <source>J Crit Care</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>61</volume>
            <fpage>138</fpage>
            <page-range>138-143</page-range>
            <pub-id pub-id-type="pmid">33161242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Houben</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Dodd</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.</article-title>
            <source>PLoS Med</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>10</issue>
            <fpage>e1002152</fpage>
            <pub-id pub-id-type="pmid">27780211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Coscolla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Borrell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Kato-Maeda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parkhill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Malla</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yeboah-Manu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bothamley</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mei</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bentley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Niemann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aseffa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gagneux</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans.</article-title>
            <source>Nat Genet</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>1176</fpage>
            <page-range>1176-82</page-range>
            <pub-id pub-id-type="pmid">23995134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farer</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Lowell</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meador</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Extrapulmonary tuberculosis in the United States.</article-title>
            <source>Am J Epidemiol</source>
            <year>1979</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>205</fpage>
            <page-range>205-17</page-range>
            <pub-id pub-id-type="pmid">425959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comstock</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of tuberculosis.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>125</volume>
            <issue>3 Pt 2</issue>
            <fpage>8</fpage>
            <page-range>8-15</page-range>
            <pub-id pub-id-type="pmid">7073104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dheda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Maartens</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Mar</month>
            <day>19</day>
            <volume>387</volume>
            <issue>10024</issue>
            <fpage>1211</fpage>
            <page-range>1211-26</page-range>
            <pub-id pub-id-type="pmid">26377143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hagan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nathani</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Clinical review: tuberculosis on the intensive care unit.</article-title>
            <source>Crit Care</source>
            <year>2013</year>
            <month>Sep</month>
            <day>27</day>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>240</fpage>
            <pub-id pub-id-type="pmid">24093433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guirado</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schlesinger</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease.</article-title>
            <source>Front Immunol</source>
            <year>2013</year>
            <volume>4</volume>
            <fpage>98</fpage>
            <pub-id pub-id-type="pmid">23626591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ba&#x000f1;uls</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Sanou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Anh</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Godreuil</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium tuberculosis: ecology and evolution of a human bacterium.</article-title>
            <source>J Med Microbiol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>64</volume>
            <issue>11</issue>
            <fpage>1261</fpage>
            <page-range>1261-1269</page-range>
            <pub-id pub-id-type="pmid">26385049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fedrizzi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Meehan</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Grottola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giacobazzi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fregni Serpini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tagliazucchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fabio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bettua</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bertorelli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De Sanctis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rumpianesi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pecorari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jousson</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tortoli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Segata</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Genomic characterization of Nontuberculous Mycobacteria.</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>Mar</month>
            <day>27</day>
            <volume>7</volume>
            <fpage>45258</fpage>
            <pub-id pub-id-type="pmid">28345639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cousins</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Bastida</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cataldi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Quse</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Redrobe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dow</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Duignan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dupont</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Loureiro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Alito</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zumarraga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bernardelli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov.</article-title>
            <source>Int J Syst Evol Microbiol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>53</volume>
            <issue>Pt 5</issue>
            <fpage>1305</fpage>
            <page-range>1305-1314</page-range>
            <pub-id pub-id-type="pmid">13130011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Converse</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Mougous</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Leavell</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Leary</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bertozzi</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2003</year>
            <month>May</month>
            <day>13</day>
            <volume>100</volume>
            <issue>10</issue>
            <fpage>6121</fpage>
            <page-range>6121-6</page-range>
            <pub-id pub-id-type="pmid">12724526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jasmer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Nahid</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hopewell</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Latent tuberculosis infection.</article-title>
            <source>N Engl J Med</source>
            <year>2002</year>
            <month>Dec</month>
            <day>05</day>
            <volume>347</volume>
            <issue>23</issue>
            <fpage>1860</fpage>
            <page-range>1860-6</page-range>
            <pub-id pub-id-type="pmid">12466511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Mitchison</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Counts of viable tubercle bacilli in sputum related to smear and culture gradings.</article-title>
            <source>Med Lab Sci</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-8</page-range>
            <pub-id pub-id-type="pmid">1487984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwan</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Ernst</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>HIV and tuberculosis: a deadly human syndemic.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>351</fpage>
            <page-range>351-76</page-range>
            <pub-id pub-id-type="pmid">21482729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <collab>GBD 2015 Mortality and Causes of Death Collaborators</collab>
            <article-title>Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Oct</month>
            <day>08</day>
            <volume>388</volume>
            <issue>10053</issue>
            <fpage>1459</fpage>
            <page-range>1459-1544</page-range>
            <pub-id pub-id-type="pmid">27733281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fogel</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis: a disease without boundaries.</article-title>
            <source>Tuberculosis (Edinb)</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>527</fpage>
            <page-range>527-31</page-range>
            <pub-id pub-id-type="pmid">26198113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaheen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>BR</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis in 2020 - New Approaches to a Continuing Global Health Crisis.</article-title>
            <source>N Engl J Med</source>
            <year>2020</year>
            <month>Apr</month>
            <day>02</day>
            <volume>382</volume>
            <issue>14</issue>
            <fpage>e26</fpage>
            <pub-id pub-id-type="pmid">32242354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <collab>GBD 2017 Disease and Injury Incidence and Prevalence Collaborators</collab>
            <article-title>Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Nov</month>
            <day>10</day>
            <volume>392</volume>
            <issue>10159</issue>
            <fpage>1789</fpage>
            <page-range>1789-1858</page-range>
            <pub-id pub-id-type="pmid">30496104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tiberi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Sulis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vaghela</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rendon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mello</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zumla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pontali</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The cursed duet today: Tuberculosis and HIV-coinfection.</article-title>
            <source>Presse Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>46</volume>
            <issue>2 Pt 2</issue>
            <fpage>e23</fpage>
            <page-range>e23-e39</page-range>
            <pub-id pub-id-type="pmid">28256380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bierman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gardam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis infection in the United States: national trends over three decades.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2008</year>
            <month>Feb</month>
            <day>15</day>
            <volume>177</volume>
            <issue>4</issue>
            <fpage>455</fpage>
            <page-range>455-60</page-range>
            <pub-id pub-id-type="pmid">18029790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Gastrectomy correlates with increased risk of pulmonary tuberculosis: A population-based cohort study in Taiwan.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>97</volume>
            <issue>27</issue>
            <fpage>e11388</fpage>
            <pub-id pub-id-type="pmid">29979430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boisson-Dupuis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bustamante</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>El-Baghdadi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Camcioglu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Parvaneh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>El Azbaoui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agader</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hassani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>El Hafidi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mrani</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Jouhadi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ailal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Najib</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reisli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zamani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yosunkaya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gulle-Girit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yildiran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cipe</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Torun</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Metin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Atikan</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Hatipoglu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aydogmus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kilic</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Dogu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Karaca</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aksu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kutukculer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Keser-Emiroglu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Somer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tanir</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aytekin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Adimi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mahdaviani</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Mamishi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bousfiha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanal</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mansouri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Casanova</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Abel</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.</article-title>
            <source>Immunol Rev</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>264</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-20</page-range>
            <pub-id pub-id-type="pmid">25703555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turner</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Bothamley</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Cough and the transmission of tuberculosis.</article-title>
            <source>J Infect Dis</source>
            <year>2015</year>
            <month>May</month>
            <day>01</day>
            <volume>211</volume>
            <issue>9</issue>
            <fpage>1367</fpage>
            <page-range>1367-72</page-range>
            <pub-id pub-id-type="pmid">25387581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurtulu&#x0015f;</surname>
                <given-names>&#x0015e;</given-names>
              </name>
              <name>
                <surname>Can</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sak</surname>
                <given-names>ZHA</given-names>
              </name>
            </person-group>
            <article-title>New perspective on rise of tuberculosis cases: communal living.</article-title>
            <source>Cent Eur J Public Health</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>302</fpage>
            <page-range>302-305</page-range>
            <pub-id pub-id-type="pmid">33338367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanifa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Corbett</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Fielding</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Churchyard</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of latent tuberculosis infection among gold miners in South Africa.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-46</page-range>
            <pub-id pub-id-type="pmid">19105877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrews</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Walensky</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township.</article-title>
            <source>J Infect Dis</source>
            <year>2014</year>
            <month>Aug</month>
            <day>15</day>
            <volume>210</volume>
            <issue>4</issue>
            <fpage>597</fpage>
            <page-range>597-603</page-range>
            <pub-id pub-id-type="pmid">24610874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zelner</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Becerra</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Galea</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lecca</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Calderon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yataco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Contreras</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Grenfell</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting.</article-title>
            <source>Am J Epidemiol</source>
            <year>2014</year>
            <month>Oct</month>
            <day>15</day>
            <volume>180</volume>
            <issue>8</issue>
            <fpage>853</fpage>
            <page-range>853-61</page-range>
            <pub-id pub-id-type="pmid">25190676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Post</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Moreira</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Wainwright</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kreiswirth</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Tanverdi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mathema</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ramaswamy</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Walther</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Steyn</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Bekker</surname>
                <given-names>LG</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity.</article-title>
            <source>Infect Immun</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>71</volume>
            <issue>12</issue>
            <fpage>7099</fpage>
            <page-range>7099-108</page-range>
            <pub-id pub-id-type="pmid">14638800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cords</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Horsburgh</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>JR</given-names>
              </name>
              <collab>Pediatric TB Contact Studies Consortium</collab>
            </person-group>
            <article-title>The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>Mar</month>
            <day>21</day>
            <volume>395</volume>
            <issue>10228</issue>
            <fpage>973</fpage>
            <page-range>973-984</page-range>
            <pub-id pub-id-type="pmid">32199484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elkington</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lerm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mahon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pienaar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaushal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schlesinger</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>In Vitro Granuloma Models of Tuberculosis: Potential and Challenges.</article-title>
            <source>J Infect Dis</source>
            <year>2019</year>
            <month>May</month>
            <day>24</day>
            <volume>219</volume>
            <issue>12</issue>
            <fpage>1858</fpage>
            <page-range>1858-1866</page-range>
            <pub-id pub-id-type="pmid">30929010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rastogi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of pathogenicity in mycobacteria.</article-title>
            <source>Biochimie</source>
            <year>1988</year>
            <month>Aug</month>
            <volume>70</volume>
            <issue>8</issue>
            <fpage>1101</fpage>
            <page-range>1101-20</page-range>
            <pub-id pub-id-type="pmid">3147701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>463</fpage>
            <page-range>463-96</page-range>
            <pub-id pub-id-type="pmid">12857778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>A phylogenomic analysis of the Actinomycetales mce operons.</article-title>
            <source>BMC Genomics</source>
            <year>2007</year>
            <month>Feb</month>
            <day>26</day>
            <volume>8</volume>
            <fpage>60</fpage>
            <pub-id pub-id-type="pmid">17324287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Porcelli</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Glickman</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.</article-title>
            <source>J Exp Med</source>
            <year>2005</year>
            <month>Feb</month>
            <day>21</day>
            <volume>201</volume>
            <issue>4</issue>
            <fpage>535</fpage>
            <page-range>535-43</page-range>
            <pub-id pub-id-type="pmid">15710652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voulhoux</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ize</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vasil</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lazdunski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Filloux</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Involvement of the twin-arginine translocation system in protein secretion via the type II pathway.</article-title>
            <source>EMBO J</source>
            <year>2001</year>
            <month>Dec</month>
            <day>03</day>
            <volume>20</volume>
            <issue>23</issue>
            <fpage>6735</fpage>
            <page-range>6735-41</page-range>
            <pub-id pub-id-type="pmid">11726509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandey</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sassetti</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterial persistence requires the utilization of host cholesterol.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2008</year>
            <month>Mar</month>
            <day>18</day>
            <volume>105</volume>
            <issue>11</issue>
            <fpage>4376</fpage>
            <page-range>4376-80</page-range>
            <pub-id pub-id-type="pmid">18334639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milburn</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Primary tuberculosis.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2001</year>
            <month>May</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>133</fpage>
            <page-range>133-41</page-range>
            <pub-id pub-id-type="pmid">11371768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stead</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Kerby</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Schlueter</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Jordahl</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>The clinical spectrum of primary tuberculosis in adults. Confusion with reinfection in the pathogenesis of chronic tuberculosis.</article-title>
            <source>Ann Intern Med</source>
            <year>1968</year>
            <month>Apr</month>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>731</fpage>
            <page-range>731-45</page-range>
            <pub-id pub-id-type="pmid">5642961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>POULSEN</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Some clinical features of tuberculosis.</article-title>
            <source>Acta Tuberc Scand</source>
            <year>1957</year>
            <volume>33</volume>
            <issue>1-2</issue>
            <fpage>37</fpage>
            <page-range>37-92; concl</page-range>
            <pub-id pub-id-type="pmid">13424392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gottlieb</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis: a focused review for the emergency medicine clinician.</article-title>
            <source>Am J Emerg Med</source>
            <year>2020</year>
            <month>May</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>1014</fpage>
            <page-range>1014-1022</page-range>
            <pub-id pub-id-type="pmid">31902701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlossberg</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Acute tuberculosis.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <page-range>139-46</page-range>
            <pub-id pub-id-type="pmid">20171549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barry</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Boshoff</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Dartois</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ehrt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schnappinger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.</article-title>
            <source>Nat Rev Microbiol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>845</fpage>
            <page-range>845-55</page-range>
            <pub-id pub-id-type="pmid">19855401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gill</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Harik</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Whiddon</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Mittler</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>A replication clock for Mycobacterium tuberculosis.</article-title>
            <source>Nat Med</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>211</fpage>
            <page-range>211-4</page-range>
            <pub-id pub-id-type="pmid">19182798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacGregor</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>A year's experience with tuberculosis in a private urban teaching hospital in the postsanatorium era.</article-title>
            <source>Am J Med</source>
            <year>1975</year>
            <month>Feb</month>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-8</page-range>
            <pub-id pub-id-type="pmid">1115069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Asch</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gelberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A population-based survey of tuberculosis symptoms: how atypical are atypical presentations?</article-title>
            <source>Clin Infect Dis</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>293</fpage>
            <page-range>293-9</page-range>
            <pub-id pub-id-type="pmid">10671331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sgaragli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Frosini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Human Tuberculosis I. Epidemiology, Diagnosis and Pathogenetic Mechanisms.</article-title>
            <source>Curr Med Chem</source>
            <year>2016</year>
            <volume>23</volume>
            <issue>25</issue>
            <fpage>2836</fpage>
            <page-range>2836-2873</page-range>
            <pub-id pub-id-type="pmid">27281297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>LoBue</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Desmond</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Loeffler</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mazurek</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richeldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salfinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shinnick</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Warshauer</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Jan</month>
            <day>15</day>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>e1</fpage>
            <page-range>e1-e33</page-range>
            <pub-id pub-id-type="pmid">27932390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malekmohammad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marjani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tabarsi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Baghaei</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sadr</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Naghan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Mansouri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Masjedi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Velayati</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic yield of post-bronchoscopy sputum smear in pulmonary tuberculosis.</article-title>
            <source>Scand J Infect Dis</source>
            <year>2012</year>
            <month>May</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>369</fpage>
            <page-range>369-73</page-range>
            <pub-id pub-id-type="pmid">22497518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nahid</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dorman</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Alipanah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cattamanchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaisson</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chaisson</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Grzemska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Higashi</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Hopewell</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Keshavjee</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Lienhardt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Menzies</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Merrifield</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Narita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Peloquin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Raftery</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saukkonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schaaf</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Sotgiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Starke</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Migliori</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Vernon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Oct</month>
            <day>01</day>
            <volume>63</volume>
            <issue>7</issue>
            <fpage>e147</fpage>
            <page-range>e147-e195</page-range>
            <pub-id pub-id-type="pmid">27516382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hadad</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Dietze</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maciel</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Sewali</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gitta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Okwera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mugerwa</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Alcaneses</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Quelapio</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Tupasi</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Horter</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Debanne</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Eisenach</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Boom</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2009</year>
            <month>Sep</month>
            <day>15</day>
            <volume>180</volume>
            <issue>6</issue>
            <fpage>558</fpage>
            <page-range>558-63</page-range>
            <pub-id pub-id-type="pmid">19542476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Small</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>PI</given-names>
              </name>
            </person-group>
            <article-title>Management of tuberculosis in the United States.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Jul</month>
            <day>19</day>
            <volume>345</volume>
            <issue>3</issue>
            <fpage>189</fpage>
            <page-range>189-200</page-range>
            <pub-id pub-id-type="pmid">11463015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaulk</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Kazandjian</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel.</article-title>
            <source>JAMA</source>
            <year>1998</year>
            <month>Mar</month>
            <day>25</day>
            <volume>279</volume>
            <issue>12</issue>
            <fpage>943</fpage>
            <page-range>943-8</page-range>
            <pub-id pub-id-type="pmid">9544769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LoBue</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2005</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>501</fpage>
            <page-range>501-6</page-range>
            <pub-id pub-id-type="pmid">15875920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Snider</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine supplementation during isoniazid therapy.</article-title>
            <source>Tubercle</source>
            <year>1980</year>
            <month>Dec</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-6</page-range>
            <pub-id pub-id-type="pmid">6269259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vernon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Benator</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bozeman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.</article-title>
            <source>Lancet</source>
            <year>1999</year>
            <month>May</month>
            <day>29</day>
            <volume>353</volume>
            <issue>9167</issue>
            <fpage>1843</fpage>
            <page-range>1843-7</page-range>
            <pub-id pub-id-type="pmid">10359410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masur</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Pau</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>JE</given-names>
              </name>
              <collab>National Institutes of Health</collab>
              <collab>Centers for Disease Control and Prevention</collab>
              <collab>HIV Medicine Association of the Infectious Diseases Society of America</collab>
            </person-group>
            <article-title>Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>May</month>
            <volume>58</volume>
            <issue>9</issue>
            <fpage>1308</fpage>
            <page-range>1308-11</page-range>
            <pub-id pub-id-type="pmid">24585567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000fc;lbay</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>G&#x000fc;rkan</surname>
                <given-names>OU</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Onen</surname>
                <given-names>ZP</given-names>
              </name>
              <name>
                <surname>Erkekol</surname>
                <given-names>FO</given-names>
              </name>
              <name>
                <surname>Ba&#x000e7;&#x000e7;io&#x0011f;lu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Acican</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis.</article-title>
            <source>Respir Med</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>100</volume>
            <issue>10</issue>
            <fpage>1834</fpage>
            <page-range>1834-42</page-range>
            <pub-id pub-id-type="pmid">16517138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Valiquette</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pelletier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parisien</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rocher</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Menzies</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2003</year>
            <month>Jun</month>
            <day>01</day>
            <volume>167</volume>
            <issue>11</issue>
            <fpage>1472</fpage>
            <page-range>1472-7</page-range>
            <pub-id pub-id-type="pmid">12569078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steele</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Burk</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>DesPrez</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Toxic hepatitis with isoniazid and rifampin. A meta-analysis.</article-title>
            <source>Chest</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>99</volume>
            <issue>2</issue>
            <fpage>465</fpage>
            <page-range>465-71</page-range>
            <pub-id pub-id-type="pmid">1824929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brinkmann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Diel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Feiterna-Sperling</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hauer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heyckendorf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nienhaus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Otto-Knapp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Priwitzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rumetshofer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schenkel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schoch</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;nfeld</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stahlmann</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)].</article-title>
            <source>Pneumologie</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>325</fpage>
            <page-range>325-397</page-range>
            <pub-id pub-id-type="pmid">28651293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seung</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Keshavjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rich</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.</article-title>
            <source>Cold Spring Harb Perspect Med</source>
            <year>2015</year>
            <month>Apr</month>
            <day>27</day>
            <volume>5</volume>
            <issue>9</issue>
            <fpage>a017863</fpage>
            <pub-id pub-id-type="pmid">25918181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Ou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Pang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>National survey of drug-resistant tuberculosis in China.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>Jun</month>
            <day>07</day>
            <volume>366</volume>
            <issue>23</issue>
            <fpage>2161</fpage>
            <page-range>2161-70</page-range>
            <pub-id pub-id-type="pmid">22670902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falzon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jaramillo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;nemann</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Arentz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bayona</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blanc</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Caminero</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Duncombe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fitzpatrick</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gebhard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Getahun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Henkens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holtz</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Keravec</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Keshavjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kulier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leimane</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lienhardt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mariandyshev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Migliori</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Mirzayev</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mitnick</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Nunn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nwagboniwe</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Oxlade</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Palmero</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pavlinac</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Quelapio</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Raviglione</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rich</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Royce</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>R&#x000fc;sch-Gerdes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Salakaia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sarin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sculier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Varaine</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vitoria</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wares</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Weyer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Zignol</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.</article-title>
            <source>Eur Respir J</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>516</fpage>
            <page-range>516-28</page-range>
            <pub-id pub-id-type="pmid">21828024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blaya</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Cegielski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Contreras</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Asencios</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bayona</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paciorek</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting.</article-title>
            <source>Epidemiol Infect</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>139</volume>
            <issue>11</issue>
            <fpage>1784</fpage>
            <page-range>1784-93</page-range>
            <pub-id pub-id-type="pmid">21205434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iketleng</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lessells</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dlamini</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Mogashoa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mupfumi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moyo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gaseitsiwe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Oliveira</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title><italic>Mycobacterium tuberculosis</italic> Next-Generation Whole Genome Sequencing: Opportunities and Challenges.</article-title>
            <source>Tuberc Res Treat</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>1298542</fpage>
            <pub-id pub-id-type="pmid">30631597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wells</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Cegielski</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Laserson</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Holtz</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Finlay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Castro</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Weyer</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>HIV infection and multidrug-resistant tuberculosis: the perfect storm.</article-title>
            <source>J Infect Dis</source>
            <year>2007</year>
            <month>Aug</month>
            <day>15</day>
            <volume>196 Suppl 1</volume>
            <fpage>S86</fpage>
            <page-range>S86-107</page-range>
            <pub-id pub-id-type="pmid">17624830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>THOMPSON</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of fatal pulmonary hemorrhage in tuberculosis.</article-title>
            <source>Am J Surg</source>
            <year>1955</year>
            <month>Mar</month>
            <volume>89</volume>
            <issue>3</issue>
            <fpage>637</fpage>
            <page-range>637-44</page-range>
            <pub-id pub-id-type="pmid">13228824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>WILDER</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>BEACHAM</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>RAVITCH</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous pneumothorax complicating cavitary tuberculosis.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>1962</year>
            <month>May</month>
            <volume>43</volume>
            <fpage>561</fpage>
            <page-range>561-73</page-range>
            <pub-id pub-id-type="pmid">14006972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenzweig</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Stead</surname>
                <given-names>WW</given-names>
              </name>
            </person-group>
            <article-title>The role of tuberculosis and other forms of bronchopulmonary necrosis in the pathogenesis of bronchiectasis.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1966</year>
            <month>May</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>769</fpage>
            <page-range>769-85</page-range>
            <pub-id pub-id-type="pmid">5296012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Rehman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Azueta</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary gangrene occurring as a complication of pulmonary tuberculosis.</article-title>
            <source>Chest</source>
            <year>1980</year>
            <month>Jan</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>76</fpage>
            <page-range>76-80</page-range>
            <pub-id pub-id-type="pmid">7351153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenner</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kleinerman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Metayer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lubin</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Previous pulmonary diseases and risk of lung cancer in Gansu Province, China.</article-title>
            <source>Int J Epidemiol</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>118</fpage>
            <page-range>118-24</page-range>
            <pub-id pub-id-type="pmid">11171871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Page</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Byanyima</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hosmane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Onyachi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Opira</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sawyer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual&#x000a0;cavitation.</article-title>
            <source>Eur Respir J</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>53</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">30705126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kethireddy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Mirzanejad</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Maki</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Arabi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lapinsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parrillo</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <collab>Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Group</collab>
            </person-group>
            <article-title>Mycobacterium tuberculosis septic shock.</article-title>
            <source>Chest</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>144</volume>
            <issue>2</issue>
            <fpage>474</fpage>
            <page-range>474-482</page-range>
            <pub-id pub-id-type="pmid">23429859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baily</surname>
                <given-names>GV</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis prevention Trial, Madras.</article-title>
            <source>Indian J Med Res</source>
            <year>1980</year>
            <month>Jul</month>
            <volume>72 Suppl</volume>
            <fpage>1</fpage>
            <page-range>1-74</page-range>
            <pub-id pub-id-type="pmid">7005086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrera</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Livchits</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nardell</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>381</fpage>
            <page-range>381-4</page-range>
            <pub-id pub-id-type="pmid">25859991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cegielski</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>McGaha</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Wolfgang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Hassell</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Robison</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Eliminating tuberculosis one neighborhood at a time.</article-title>
            <source>Am J Public Health</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>103</volume>
            <issue>7</issue>
            <fpage>1292</fpage>
            <page-range>1292-300</page-range>
            <pub-id pub-id-type="pmid">23078465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowdy</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Azman</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Mathema</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Transforming the fight against tuberculosis: targeting catalysts of transmission.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Oct</month>
            <day>15</day>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>1123</fpage>
            <page-range>1123-9</page-range>
            <pub-id pub-id-type="pmid">24982034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tameris</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Hatherill</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Landry</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Scriba</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Snowden</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shea</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McClain</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Hussey</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Hanekom</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Mahomed</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McShane</surname>
                <given-names>H</given-names>
              </name>
              <collab>MVA85A 020 Trial Study Team</collab>
            </person-group>
            <article-title>Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.</article-title>
            <source>Lancet</source>
            <year>2013</year>
            <month>Mar</month>
            <day>23</day>
            <volume>381</volume>
            <issue>9871</issue>
            <fpage>1021</fpage>
            <page-range>1021-8</page-range>
            <pub-id pub-id-type="pmid">23391465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hopewell</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Uplekar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raviglione</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>International standards for tuberculosis care.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>11</issue>
            <fpage>710</fpage>
            <page-range>710-25</page-range>
            <pub-id pub-id-type="pmid">17067920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-120843.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M'imunya</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kredo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Volmink</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Patient education and counselling for promoting adherence to treatment for tuberculosis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2012</year>
            <month>May</month>
            <day>16</day>
            <volume>2012</volume>
            <issue>5</issue>
            <fpage>CD006591</fpage>
            <pub-id pub-id-type="pmid">22592714</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
